Sodium Hyaluronate With Sodium Chondroitin Sulfate Ophthalmic Solution
Anterior Segment Procedure
BIO-HYALUR LVD is indicated for use whenever protection and lubrication of delicate cells of tissues are needed in anterior segment procedures including cataract extraction and intraocular lens implantation.
Protects the corneal endothelium and other ocular tissues
Maintains a deep chamber during anterior segment surgeries
Enhances visualization during the surgical procedure
The viscoelasticity of the solution maintains the normal position of the vitreous face, thus preventing formation of a postoperative flat chamber
| Raw Material | Sodium Hyaluronate content (3.0% W/V) & Sodium Chondroitin Sulfate content (4.0% W/V) |
|---|---|
| Viscosity (@ 25°C) | 40,000 +/- 20,000 mPas |
| pH | 6.5 to 7.6 |
| Osmolarity | 285 – 365 mOsm/kg |
| Shelf Life | 2 years from the date of manufacturing |
| Storage | Store between 2°C to 8°C degrees Do not Freeze. Protect from light |
| Application / Intended Use | Anterior segment procedures |
Bio-Hyalur LVD is a combination of Sodium Hyaluronate 3% & Sodium Chondroitin Sulphate 4% Ophthalmic Solutions, supplied in 1.0 ml PFS (BD Glass Syringe) with 27G Sterile Cannula.
Battig Treuhand AG
Obergrundstrasse 17,
6002, Luzern,
Switzerland
